- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02814084
Prevena Incision Management (Prevena)
Effect of the Prevena Incision Management System on Sternal Wound Edge Perfusion in Patients Undergoing CABG With Bilateral Mammary Artery Grafts
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Coronary artery bypass is the gold standard surgical treatment of patients with complex coronary disease. It is a common operation and more than 16000 procedures per year are carried out in the UK. Recent publications suggest that during the bypass procedure both left and right internal mammary arteries should be used to bypass coronary stenoses. It was noted that using both internal mammary arteries will result in even better long term survival with improved freedom from cardiac events such as myocardial infarction or further coronary intervention than using. The major drawback of using both internal mammary arteries is the increased risk of sternal wound infection and breakdown. The investigators will use Near Infra-Red Spectroscopy (NIRS) to assess the wound edge oxygenation delivery. The NIRS INVOS system the investigators use within Sheffield Teaching Hospitals can measure oxygenation of soft tissue to a certain depth making it suitable for the assessment of wound edge oxygen delivery. Prevena is commercially available and has a CE mark.
The Prevena wound management system differs from conventional wound dressings, it applies negative pressure to the closed wound for 7 days. Wound complications/infections are decreased when this type of wound management system is used. Studies suggest that Prevena achieves these outcomes because of an increase of perfusion in the wound edges and keeping the wound dry. Patients will be randomised to either the Prevena wound management or their standard of care NHS wound management for their procedure. The oxygenation and outcomes of the wounds will be compared through data collection and the patients followed up during their routine inpatient care and 6 week outpatient appointment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
England
-
Sheffield, England, United Kingdom, S10 2JF
- Sheffield Teaching Hospitals NHS FT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Eligible patients are those who require isolated coronary artery bypass surgery, who need at least 2 bypass grafts, and who are deemed suitable by the operating surgeon to have both right and left internal mammary arteries harvested as conduits
Exclusion Criteria:
- Require additional procedures in addition to the coronary bypass or need for internal mammary artery harvest for feasibility study
- Who are deemed by the operating surgeon as unsuitable for bilateral internal mammary artery harvest because of
- Age (75 or older where prognostic benefit of using both internal mammary arteries has been questioned),
- Obesity with a BMI which is higher than 35 (increased risks of wound infection)
- Diabetes (of any type) (increased risks of infection.)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Bilateral Internal Mammary Artery grafts
Standard care wound dressings used as part of coronary artery bypass graft operation
|
Sternal Wound Edge Oxygenation in patients undergoing Coronary Artery bypass surgery with Bilateral Internal Mammary Artery grafts
|
Experimental: Prevena
Prevena dressing used as part of coronary artery bypass graft operation.
|
The Prevena wound management system applies negative pressure to the closed wound for up to 7 days and is associated with lower rates of surgical site infection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NIRS measurement of the inferior third of the parasternal region and left forearm assessment
Time Frame: Measurements taken up to 6 weeks post sternotomy wound dressing
|
NIRS assessment of the left forearm will also be performed at the same time acting as a control to take into account factors other than wound perfusion that influence oxygen delivery.
The difference of the two readings will be the final measurement used for comparison.
|
Measurements taken up to 6 weeks post sternotomy wound dressing
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wounds will be scored according to the ASEPSIS scoring system
Time Frame: On the day of dressing removal and at the 6 week postoperative outpatient visit.
|
This will be done by an observer who is blinded to the dressing used.
|
On the day of dressing removal and at the 6 week postoperative outpatient visit.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Norman Briffa, Sheffield Teaching Hospitals NHS Foundation Trust
Publications and helpful links
General Publications
- Holmes C, Briffa N. Patient-Reported Outcome Measures (PROMS) in patients undergoing heart valve surgery: why should we measure them and which instruments should we use? Open Heart. 2016 May 5;3(1):e000315. doi: 10.1136/openhrt-2015-000315. eCollection 2016.
- Rowe R, Iqbal J, Murali-Krishnan R, Sultan A, Orme R, Briffa N, Denvir M, Gunn J. Role of frailty assessment in patients undergoing cardiac interventions. Open Heart. 2014 Feb 1;1(1):e000033. doi: 10.1136/openhrt-2013-000033. eCollection 2014.
- Briffa N. Surgeons' attitudes to intraoperative death. Cardiac surgeons might have different attitudes. BMJ. 2001 Aug 11;323(7308):341-2. No abstract available.
- Solodkyy A, Shalhoub J, Chetty G, Briffa NP. A rare case of giant coronary artery aneurysm in the context of multiple arterial aneurysms. Int J Surg Case Rep. 2012;3(7):311-3. doi: 10.1016/j.ijscr.2012.03.023. Epub 2012 Mar 29.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH18497
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Event
-
Hospices Civils de LyonCompleted
-
HaEmek Medical Center, IsraelCompleted
-
Datascope Patient MonitoringCompletedCardiac EventUnited States
-
Alder Hey Children's NHS Foundation TrustWithdrawn
-
Centre Hospitalier Universitaire, AmiensBaxter Healthcare CorporationRecruiting
-
University of California, San FranciscoWithdrawnCardiac Event RiskUnited States
-
Liverpool John Moores UniversityLiverpool Heart and Chest Hospital NHS Foundation Trust; University Hospitals... and other collaboratorsRecruiting
-
Mayo ClinicJohns Hopkins University; University of California, Irvine; University of Mississippi...Not yet recruitingCardiovascular Diseases | Telemedicine | Cardiac EventUnited States
-
Neutec Ar-Ge San ve Tic A.ŞWithdrawnGERD | Cardiac Event | Safety IssuesTurkey
Clinical Trials on Bilateral Internal Mammary Artery grafts
-
Rigshospitalet, DenmarkLundbeck Foundation; Danish Heart Foundation; Copenhagen Hospital CorporationUnknownAngina Pectoris | Ischemic Heart Disease | Coronary ArteriosclerosisDenmark
-
Cancer Institute and Hospital, Chinese Academy...Zhejiang Cancer Hospital; Shanxi Province Cancer Hospital; Wuhan University; Fudan... and other collaboratorsRecruiting
-
Yonsei UniversityActive, not recruitingBreast NeoplasmsKorea, Republic of
-
Voon Hian YanNot yet recruitingPlacenta Accreta
-
Catholic University, ItalyUnknown
-
Shandong Cancer Hospital and InstituteHenan Cancer Hospital; The Affiliated Hospital of Qingdao UniversityUnknown
-
HaEmek Medical Center, IsraelCompleted
-
Deng DongruiCompletedPlacenta Accreta | Placenta Previa
-
Emilia BagiellaNational Heart, Lung, and Blood Institute (NHLBI)Completed
-
Mansoura University HospitalCompletedPlacenta AccretaEgypt